Eli Lilly and Company's latest 10-K report for the year ended December 31, 2024, reveals significant financial growth. The company reported a revenue of $45,042.7 million, marking a 32% increase from ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Ireland's pharmaceutical industry shipped billions' worth of goods to the U.S., but face threats from Trump 2.0.

A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Just five sell-side analysts rate Apple Inc.’s stock at the equivalent of sell, counting Jefferies’ Edison Lee, who turned bearish late Monday. Lee has three reasons for his pessimism, as he t ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

Eli Lilly and Company (NYSE: LLY) is one of two pharmaceutical stocks behind the weight loss drug craze that has impacted the ...

Aja Beckett quit her job after her app for tracking weight-loss shots, Shotsy, took off on Reddit.

Beyond treating diabetes and helping people lose weight, GLP-1s may also improve libido. But the reasons are as complex as ...

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

We came across a bullish thesis on Eli Lilly and Company (LLY) on Substack by Kontra Investments. In this article, we will ...